B. Braun Melsungen AG
B. Braun OEM Industrial Business offers a broad range of standard products and contract manufacturing services for medical devices and pharmaceutical solutions for the healthcare industry. B. Braun OEM accompanies the customer from his product idea over the product development to the market launch of the product. B. Braun OEM offers the complete project management capabilities, customized product variations and combinations of medical devices furthermore.
B. Braun supplies healthcare markets worldwide and is employing more than 55,700 individuals. The company is currently represented in more than 64 countries and the portfolio comprises more than 120,000 pharmaceutical and medical articles.
-Contract Manufacturing Service
-Infusion and Injection Solutions
-Medical Devices for Drug Admixture
-Products for Venipuncture and Injection
Contact details :
B. Braun Melsungen AG
E-mail: info-europe@bbraunoem.com Website: http://www.bbraunoem.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
